To include your compound in the COVID-19 Resource Center, submit it here.

PreciThera raises C$36M in series A

Orphan bone disease newco PreciThera Inc. (Montreal, Canada) raised C$36 million ($28.6 million) in an oversubscribed series A

Read the full 188 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE